Form 8-K - Current report:
SEC Accession No. 0000950170-25-024228
Filing Date
2025-02-20
Accepted
2025-02-20 16:51:12
Documents
14
Period of Report
2025-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K jagx-20250219.htm   iXBRL 8-K 47098
2 EX-4.1 jagx-ex4_1.htm EX-4.1 49666
3 GRAPHIC img239560353_0.jpg GRAPHIC 87687
4 GRAPHIC img239560353_1.jpg GRAPHIC 87687
  Complete submission text file 0000950170-25-024228.txt   450302

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT jagx-20250219.xsd EX-101.SCH 24902
17 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20250219_htm.xml XML 4530
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 25646264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)